Back to all papers

Postdeployment Monitoring and Surveillance Methods, Guidelines, and Possibilities for AI in Radiology.

June 25, 2026pubmed logopapers

Authors

Venugopal VK,Khubchandani SA,Liew CJY,Kitamura FC,Takhar R,Lip G

Affiliations (9)

  • Imaging Division, Rajiv Gandhi Cancer Institute and Research Centre, Sir Chotu Ram Marg, Sector 5, Rohini, New Delhi, India 110085.
  • Academy of Research and Education, Chettinad Health City, Kelambakkam, India.
  • Department of Radiology, Grant Government Medical College and Sir J J Group of Hospitals, Mumbai, India.
  • Department of Radiology, Changi General Hospital, Singapore.
  • Department of Diagnostic Imaging, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Radiology Division, Diagnósticos da América SA (Dasa Inova), São Paulo, Brazil.
  • Imaging Division, Apollo Radiology International, New Delhi, India.
  • Department of Radiology, National Health Service, Grampian, Aberdeen, UK.
  • Clinical Director, North East Scotland Breast Screening Service, Aberdeen, UK.

Abstract

As radiology AI systems move from predeployment validation to routine radiology practice, attention is shifting toward postdeployment monitoring and postmarket surveillance in a total product life cycle (TPLC) paradigm. In an operational sense, the human clinical oversight can be positioned along a spectrum encompassing human-in-the-loop (HITL), human-in-a-parallel loop (HIPL), human-on-the-loop (HOTL), human-over-the-loop (HOVL), and human-out-of-the-loop (HOOTL) models. Each of these models offers a trade between the verification workload and autonomy and risk. The authors provide a deeper understanding of the definitions first and then present HOTL as a pragmatic model of human-AI oversight for high-stakes imaging, demonstrating a balance between the trade-offs and benefits. The proposed monitoring system is based on two families of data points that do not require immediate determination of the ground truth, namely temporal stability of inputs and outputs and predictive divergence relative to a deployment initiation baseline. The authors also bring uncertainty quantification into the fray as a third element in helping prioritize reviews when labels are delayed or not continually feasible. The described threshold-based alerting system is paired with tiered escalation mechanisms and root cause analysis to distinguish degradation of the AI algorithm from data or integration pipeline issues. The result is an education-first proactive road map for postdeployment monitoring that allows preservation and prioritization of patient safety while enabling responsible scaling of radiology AI. <sup>©</sup>RSNA, 2026 See the invited commentary by Rouzrokh and Rouzrokh in this issue.

Topics

RadiologyProduct Surveillance, PostmarketingArtificial IntelligenceJournal ArticleReview

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.